INDSWFTLTD
INDSWFTLTD (INDSWFTLTD) live share price today at NSE / BSE
Thu, 17 Sept 2026, 02:26 PM
About INDSWFTLTD
Ind-Swift Ltd is an Indian pharmaceutical company specializing in the manufacturing and marketing of formulation drugs and active pharmaceutical ingredients (APIs) for domestic and international markets. Established in 1986, the company’s product portfolio spans therapeutic areas including cardiovascular, anti-infectives, central nervous system (CNS) drugs, and anti-diabetics, among others. Ind-Swift operates advanced manufacturing facilities compliant with global regulatory standards, supplying to more than 50 countries and holding several international accreditations such as US FDA and WHO-GMP.
52 Week Range
Current Signal
red
Open
INR 15.16
High
INR 17.82
Low
INR 15.15
Prev. Close
INR 15.76
Volume
6,45,158
Avg. Volume (7D)
—
Avg. Volume (10D)
—
Latest Signal
SellSell Price
INR 17.5
Close Price
INR 17.36
Change
15.43%
Signal Date
2025-07-23
Hold
No
Pattern
—
Company Snapshot
| CIN | L24230CH1986PLC006897 |
| Industry | Pharmaceuticals |
| Market Lot | 1 |
| Impact Cost | 1.73% |
| Listing Date | 13 Oct 1994 |
| BC Record Date | RD 14/08/2025 |
| Registered Address | # 781, Industrial Area, Phase-II, |
| Auditor | Jain & Associates |
Registrar
Board of Directors
Today Share Price
INDSWFTLTD
| Particulars | Details |
|---|---|
| Opening Price | INR 15.16 |
| Previous Closing Price | INR 15.76 |
| Volume of INDSWFTLTD | 6,45,158 |
| Value of Share | — |
Today NSE Share Price
INDSWFTLTD
| Particulars | Details |
|---|---|
| Live Share Price NSE India | INR 15.76 |
| Previous Closing Price | INR 15.76 |
| Open Price | INR 15.16 |
| High | INR 17.82 |
| Low | INR 15.15 |
Today BSE Share Price
INDSWFTLTD
| Particulars | Details |
|---|---|
| Live Share Price BSE India | INR 15.76 |
| Previous Closing Price | INR 15.76 |
| Open Price | INR 15.16 |
| High | INR 17.82 |
| Low | INR 15.15 |
INDSWFTLTD
Ind-Swift Ltd is an Indian pharmaceutical company specializing in the manufacturing and marketing of formulation drugs and active pharmaceutical ingredients (APIs) for domestic and international markets. Established in 1986, the company’s product portfolio spans therapeutic areas including cardiovascular, anti-infectives, central nervous system (CNS) drugs, and anti-diabetics, among others. Ind-Swift operates advanced manufacturing facilities compliant with global regulatory standards, supplying to more than 50 countries and holding several international accreditations such as US FDA and WHO-GMP.
Frequently Asked Questions – StockYaari Stock Page
Every stock page on StockYaari is built to give investors a complete picture of a company before they act on any idea. Below are the most common questions users ask about how this page works, what it shows, and how to make the most of it while researching a company.
Final Thoughts
Taken together, these sections are what make a StockYaari stock page useful for both quick decisions and deeper research. Whether someone is checking a live price during market hours, studying a company's fundamentals before investing for the long term, or simply confirming whether an analyst has an active call on a stock, everything sits in one organised place. New users are encouraged to explore each section at their own pace, since familiarity with the layout makes future research faster and more confident over time.
Track. Analyse. Outperform.
Your performance, our priority.

Platform Performance
(vs NIFTY 50)
Total Return
+24.35%
Outperformance
+12.41%
Accuracy
78%
Join 31,000+ active traders

Ready to unlock premium signals?
Sign in with your mobile number and start trading smarter today.

